ChromoTek
ChromoTek GmbH pioneers a new class of immunologic research tools derived from single domain camel antibodies for cell biology and proteomics. Founded in 2008 as a spin-off from the Ludwig-Maximilians University Munich (LMU) by a research team around Ulrich Rothbauer, ChromoTek has rapidly developed to become a renowned supplier of innovative reagents as well as a trusted service provider for big pharma. Our management team combines complementary skills and experiences that form a basis for sustained growth.
ChromoTek offers innovative research reagents based on Camelid antibodies: Our Nano-Traps are perfect tools for the rapid immuno- precipitation of proteins and their interaction partners with high specificity and efficiency. Our Boosters enhance the signal intensity of your targets in fluorescent microscopy. And our recently introduced Chromobodies® allow you to analyze endogenous proteins in living cells in real time. In addition, we provide a growing number of exceptionally specific conventional antibodies.
Last not least, our new fluorescent 2-hybrid (F2H®) assay enables you to monitor reversible protein-protein interactions in a cellular system.
ChromoTek offers innovative research reagents based on Camelid antibodies: Our Nano-Traps are perfect tools for the rapid immuno- precipitation of proteins and their interaction partners with high specificity and efficiency. Our Boosters enhance the signal intensity of your targets in fluorescent microscopy. And our recently introduced Chromobodies® allow you to analyze endogenous proteins in living cells in real time. In addition, we provide a growing number of exceptionally specific conventional antibodies.
Last not least, our new fluorescent 2-hybrid (F2H®) assay enables you to monitor reversible protein-protein interactions in a cellular system.
